BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 37323166)

  • 21. Prognostic impact of tumour spread through air space in radiological subsolid and pure solid lung adenocarcinoma.
    Zhong Y; Xu Y; Deng J; Wang T; Sun X; Chen D; Wu C; Hou L; Xie H; She Y; Xie D; Chen C
    Eur J Cardiothorac Surg; 2021 Apr; 59(3):624-632. PubMed ID: 33188689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules.
    Cho JH; Choi YS; Kim J; Kim HK; Zo JI; Shim YM
    Ann Thorac Surg; 2015 Jan; 99(1):218-22. PubMed ID: 25440277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathological characteristics and prognosis of non-lepidic invasive adenocarcinoma presenting as ground glass opacity nodule.
    Moon Y; Sung SW; Lee KY; Park JK
    J Thorac Dis; 2016 Sep; 8(9):2562-2570. PubMed ID: 27747010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathological features and prognostic implications of ground-glass opacity components on computed tomography for clinical stage I lung adenocarcinoma.
    Katsumata S; Aokage K; Ishii G; Hoshino H; Suzuki J; Miyoshi T; Tane K; Samejima J; Tsuboi M
    Surg Today; 2021 Jul; 51(7):1188-1202. PubMed ID: 33745094
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic influence of epidermal growth factor receptor mutation and radiological ground glass appearance in patients with early-stage lung adenocarcinoma.
    Aokage K; Miyoshi T; Wakabayashi M; Ikeno T; Suzuki J; Tane K; Samejima J; Tsuboi M
    Lung Cancer; 2021 Oct; 160():8-16. PubMed ID: 34365179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical features and surgical outcomes of young patients with lung adenocarcinoma manifesting as ground glass opacity.
    Qu R; Tu D; Cai Y; Ping W; Fu X
    Front Oncol; 2022; 12():979522. PubMed ID: 36185186
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prognosis of invasive adenocarcinoma presenting as ground-glass opacity on chest computed tomography after sublobar resection.
    Moon Y; Lee KY; Park JK
    J Thorac Dis; 2017 Oct; 9(10):3782-3792. PubMed ID: 29268386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic Significance of Ground-Glass Opacity Components in 5-Year Survivors With Resected Lung Adenocarcinoma.
    Shigefuku S; Shimada Y; Hagiwara M; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Ann Surg Oncol; 2021 Jan; 28(1):148-156. PubMed ID: 32920721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-Driver-Negatives versus Epidermal Growth Factor Receptor Mutants for C-Stage IA Lung Adenocarcinoma with Ground-Glass Opacity.
    Li M; Xi J; Zhang H; Jin X; Zhang J; Feng M; Zhan C; Wang Q
    Ann Thorac Cardiovasc Surg; 2022 Oct; 28(5):320-328. PubMed ID: 35644565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of ground glass opacity on computed tomography in pathological stage I pulmonary adenocarcinoma: A meta-analysis.
    Pan XL; Liao ZL; Yao H; Yan WJ; Wen DY; Wang Y; Li ZL
    World J Clin Cases; 2021 Nov; 9(33):10222-10232. PubMed ID: 34904092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors.
    Mimae T; Tsutani Y; Miyata Y; Imai K; Ito H; Nakayama H; Ikeda N; Okada M
    Ann Thorac Surg; 2020 May; 109(5):1530-1536. PubMed ID: 31981497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic implications of CT-defined ground glass opacity in clinical stage I-IIA grade 3 invasive non-mucinous pulmonary adenocarcinoma.
    Ding L; Zhao J; Yang Y; Bhuva MS; Dipendra P; Sun X
    Clin Radiol; 2024 Mar; 79(3):e353-e360. PubMed ID: 38123396
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic effect of ground-glass opacity in subcentimeter invasive lung adenocarcinoma.
    Bai J; Fu F; Sun W; Deng C; Ma Z; Wang S; Deng L; Zhang Y; Chen H
    J Thorac Dis; 2023 Apr; 15(4):1559-1571. PubMed ID: 37197537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of Pathologic Tumor Invasion and Prognosis for Ground Glass Opacity Featured Lung Adenocarcinoma.
    Ye T; Deng L; Xiang J; Zhang Y; Hu H; Sun Y; Li Y; Shen L; Wang S; Xie L; Chen H
    Ann Thorac Surg; 2018 Dec; 106(6):1682-1690. PubMed ID: 30096292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic influence of a ground-glass opacity component in hypermetabolic lung adenocarcinoma.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Jan; 61(2):249-256. PubMed ID: 34632486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prognostic role of positron emission tomography and high-resolution computed tomography in clinical stage IA lung adenocarcinoma.
    Uehara H; Tsutani Y; Okumura S; Nakayama H; Adachi S; Yoshimura M; Miyata Y; Okada M
    Ann Thorac Surg; 2013 Dec; 96(6):1958-65. PubMed ID: 24021765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Should resection extent be decided by total lesion size or solid component size in ground glass opacity-containing lung adenocarcinomas?
    Lin B; Wang R; Chen L; Gu Z; Ji C; Fang W
    Transl Lung Cancer Res; 2021 Jun; 10(6):2487-2499. PubMed ID: 34295656
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
    Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
    Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Undetectable circulating tumor DNA levels correlate with low risk of recurrence/metastasis in postoperative pathologic stage I lung adenocarcinoma patients.
    Yang W; You N; Jia M; Yeung SJ; Ou W; Yu M; Wang Y; Fu X; Zhang Z; Yang J; Lao Z; Liu Z; Zeng B; Ou Q; Wu X; Shao YW; Hong X; Wang S; Cheng C
    Lung Cancer; 2020 Aug; 146():327-334. PubMed ID: 32623075
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.